- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05960552
Perioperative Rescue Transesophageal Echocardiography in Intensive and Critical Status
Establishment and Verification of Clinical Thinking Flowchart of Rescue Transesophageal Echocardiography in the Diagnosis and Treatment of Perioperative Patients in Intensive and Critical Status
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There are 6 TEE operators who will participate in our trial, which is of restriction.
Also, the participants we scheme to include are all junior TEE operators at our institute, who have already skilled at images obtainment and interpretation. Prior to the trial initiation, all these TEE operators will be randomly assigned into either the PReTEE group or the conventional TEE group with a 1:1 ratio (3 per group). Due to another limitation of eligible patients, TEE examinations thereby for patients are not conducted by equal numbers of operators stratified by groups. Furthermore, patients will be examined by 1-4 operators and 1 expert without removing the probe when separated from cardiopulmonary bypass. The ultimate sample size we calculate is 46 TEE examinations.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chunhua Yu, MD
- Phone Number: 13811585975
- Email: yuchuh@pumch.cn
Study Contact Backup
- Name: Chunrong Wang, MD
- Phone Number: 15811176696
- Email: emancipation258@outlook.com
Study Locations
-
-
-
Beijing, China
- Recruiting
- Peking Union Medical College Hospital
-
Contact:
- Chunrong Wang, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age of 18 yr and greater;
- High-risk cardiac surgery (one of the followings): Baseline left ventricular ejection fraction < 50%, Coronary artery bypass graft combined with valve procedures, Multiple valve procedures (≥ 2), Aortic root or arch involved, Euroscore > 6, Previous cardiovascular surgery
Exclusion Criteria:
- Lack of patient consent;
- Esophageal pathology (stricture, tumor, perforation/laceration, ulcer or fistula, diverticulum);
- Hiatus hernia; Perforated viscus;
- Active/recent upper gastrointestinal (GI) bleed;
- Non-elective cardiac procedures;
- Preoperative mechanical cardiac support (ECMO, LVAD or IABP)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The PReTEE group
Prior to clinical application of PReTEE, all participants designated must receive professional training.
Within the given 120 seconds participants in the PreTEE group need to provide the leading cause with regard to difficult separation from cardiopulmonary bypass among high-risk cardiac surgical procedures.
|
Prior to clinical application of PReTEE, all participants designated must receive professional training.
They need to receive lectures focusing on the clinical thinking flowchart of rescue transesophageal echocardiography, in conjuntion with the simulator-based training.
The discriminating ability of PReTEE will be further assessed in real clinical scenario, that is, within the specified 120 seconds participants in the PreTEE group need to provide the leading causes with regard to difficult separation from cardiopulmonary bypass in high-risk cardiac surgical procedures.
All examinations will be supervised by a TEE expert owning to safety considerations but without help in views acquirement or interpretation.
After completion of study assessments, the TEE expert will perform a standard comprehensive TEE, the results of which was reported to the attending cardiac anesthesiologist in charge of the patient and the recorders.
|
|
Active Comparator: The conventional TEE group
The routine intra-operative TEE examinations are performed within the given 120 seconds before patients are separated from the cardiopulmonary bypass.
|
Before cardiopulmonary bypass separation, conventional TEE examinations will be performed within the specified 120 seconds.
Then, the expert will also perform a standard comprehensive TEE; the leading cause should also be presented to the attending anesthesiologists and recorders.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time taken in seconds in seeking out the leading cause of difficult CPB separation.
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Time will be recorded in rea-time fashion from the appearance of midesophageal 4 chamber view to the diagnose of leading cause of difficult CPB separation in both the PReTEE group and the conventional group.
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
|
The rate of successful diagnosis.
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Following the completion of TEE assessment by operators in the PreTEE group or in the conventional TEE group, the TEE expert in our center will then perform a standard comprehensive examination.
The TEE expert will also be required to provide the leading cause of difficult separation, which then be presented to the attending anesthesiologist and cardiac surgeons as the reference of therapeutic approaches.
The successful diagnosis is defined as the agreement of cause between operators in the PreTEE group or in the conventional TEE group and the expert.
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection rate of hypovolemia
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Reduction in the LV cavity indicates hypovolemia.
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
|
Detection rate of left ventricular outflow tract obstruction
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
The occurrence of SAM
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
|
Detection rate of regional wall motion abnormality
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Regional wall motion is commonly classified as 1) normal or hyperkinetic, 2) hypokinetic (reduced thickening), 3) akinetic (absence of thickening), and 4) dyskinetic (systolic thinning or aneurysmal changes
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
|
Detection rate of left ventricular systolic dysfunction
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Left ventricular systolic dysfunction can be assessed as a reduction in systolic function and an increase in diastolic dimension.
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
|
Detection rate of right ventricular systolic dysfunction
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
A TEE with a D-shaped LV on trans-gastric short axis view is suggestive of RV volume overload and systolic dysfunction
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
|
Detection rate of right ventricular outflow tract obstruction
Time Frame: From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
The occurrence of pulmonary embolism, residual thrombus or tumor is seen in the RA/ RV, leftward shift of the interatrial septum or moderate to severe tricuspid regurgitation.
|
From the time of appearance of midesophageal 4 chamber view until the time of discrimination of the leading cause of difficult separation from cardiopulmonary bypass by the TEE operator, assessed up to 120 seconds.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- K3052
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transesophageal Echocardiography
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedTransesophageal EchocardiographyTurkey
-
Cairo UniversityPrince Sultan Cardiac Center, Adult Cardiology Department.Not yet recruitingCardiac Surgery | Echocardiography, TransesophagealSaudi Arabia
-
Patrick F Wouters, MD PhDCompletedEchocardiography, Doppler | Echocardiography, Three-Dimensional | Echocardiography, Transesophageal | Echocardiography, TransthoracicBelgium
-
Centre Hospitalier Universitaire de Saint EtienneCompletedTransesophageal Echocardiography | Vena Cava SuperiorFrance
-
Uniwersytecki Szpital Kliniczny w OpoluCompletedSurgery | Fluid Responsiveness | Transesophageal EchocardiographyPoland
-
Milton S. Hershey Medical CenterCompletedEchocardiography, Transesophageal | Ventricular Function, RightUnited States
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedClinical Indications for Transesophageal EchocardiographyTurkey
-
Bruno MoraRecruitingCardiac Surgery Patients | Transesophageal Echocardiography | Cardiac AnesthesiaAustria
-
Ain Shams UniversityCompletedRadiography | Anatomic Landmarks | Echocardiography, Transesophageal | Catheterization, Central VenousEgypt
-
Medical University of ViennaUnknownTransesophageal EchocardiographyAustria
Clinical Trials on The PReTEE group
-
Second Affiliated Hospital, School of Medicine,...Unknown
-
West China Second University HospitalCompleted
-
The Affiliated Hospital of Qingdao UniversityEnrolling by invitation
-
Shenzhen Sixth People's HospitalCompleted
-
M.D. Anderson Cancer CenterCompletedPain | Pain Syndrome | Symptom ManagementUnited States
-
Aydin Adnan Menderes UniversityCompletedPrimary DysmenorrheaTurkey
-
Hacettepe UniversityCompleted
-
Region SkanePfizerCompleted
-
Akdeniz UniversityCompletedPain | Premature | PretermTurkey
-
Istanbul Medipol University HospitalRecruiting